标题
Sorafenib and HDAC inhibitors synergize with TRAIL to kill tumor cells
作者
关键词
-
出版物
JOURNAL OF CELLULAR PHYSIOLOGY
Volume 228, Issue 10, Pages 1996-2005
出版商
Wiley
发表日期
2013-05-14
DOI
10.1002/jcp.24362
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Combination therapy for hepatocellular carcinoma: Additive preclinical efficacy of the HDAC inhibitor panobinostat with sorafenib
- (2012) Anja Lachenmayer et al. JOURNAL OF HEPATOLOGY
- TRAIL Signaling and Synergy Mechanisms Used in TRAIL-Based Combination Therapies
- (2012) C. T. Hellwig et al. MOLECULAR CANCER THERAPEUTICS
- Sorafenib Enhances Pemetrexed Cytotoxicity through an Autophagy-Dependent Mechanism in Cancer Cells
- (2011) M. D. Bareford et al. CANCER RESEARCH
- Developing Histone Deacetylase Inhibitors as Anti-Cancer Therapeutics
- (2011) B. Venugopal et al. CURRENT MEDICINAL CHEMISTRY
- Sorafenib tosylate in advanced kidney cancer: past, present and future
- (2010) Camillo Porta et al. ANTI-CANCER DRUGS
- Platinum resistant cancer cells conserve sensitivity to BH3 domains and obatoclax induced mitochondrial apoptosis
- (2010) Nyree Crawford et al. APOPTOSIS
- Inhibition of MCL-1 in breast cancer cells promotes cell death in vitro and in vivo
- (2010) Clint Mitchell et al. CANCER BIOLOGY & THERAPY
- A Bax-Mediated Mechanism for Obatoclax-Induced Apoptosis of Cholangiocarcinoma Cells
- (2010) R. L. Smoot et al. CANCER RESEARCH
- Vorinostat and Sorafenib Increase CD95 Activation in Gastrointestinal Tumor Cells through a Ca2+-De novo Ceramide-PP2A-Reactive Oxygen Species-Dependent Signaling Pathway
- (2010) M. A. Park et al. CANCER RESEARCH
- The multikinase inhibitor Sorafenib induces apoptosis and sensitises endometrial cancer cells to TRAIL by different mechanisms
- (2010) D. Llobet et al. EUROPEAN JOURNAL OF CANCER
- TRAIL receptor signaling and therapeutics
- (2010) Junaid Abdulghani et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Sorafenib Activates CD95 and Promotes Autophagy and Cell Death via Src Family Kinases in Gastrointestinal Tumor Cells
- (2010) Margaret A. Park et al. MOLECULAR CANCER THERAPEUTICS
- Targeting mitochondria for cancer therapy
- (2010) Simone Fulda et al. NATURE REVIEWS DRUG DISCOVERY
- Heat Shock Protein 90 – a Potential Target in the Treatment of Human Acute Myelogenous Leukemia
- (2009) H. Reikvam et al. CURRENT CANCER DRUG TARGETS
- BCL-2 Family Inhibitors Enhance Histone Deacetylase Inhibitor and Sorafenib Lethality via Autophagy and Overcome Blockade of the Extrinsic Pathway to Facilitate Killing
- (2009) A. P. Martin et al. MOLECULAR PHARMACOLOGY
- Sorafenib and Vorinostat Kill Colon Cancer Cells by CD95-Dependent and -Independent Mechanisms
- (2009) T. Walker et al. MOLECULAR PHARMACOLOGY
- Mimicking the BH3 domain to kill cancer cells
- (2009) T Ni Chonghaile et al. ONCOGENE
- Vorinostat and Sorafenib Synergistically Kill Tumor Cells via FLIP Suppression and CD95 Activation
- (2008) G. Zhang et al. CLINICAL CANCER RESEARCH
- Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling
- (2008) Scott M. Wilhelm et al. MOLECULAR CANCER THERAPEUTICS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started